News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
632,132 Results
Type
Article (52531)
Company Profile (242)
Press Release (579359)
Section
Business (178818)
Career Advice (2815)
Deals (32385)
Drug Delivery (103)
Drug Development (79966)
Employer Resources (166)
FDA (15240)
Job Trends (14200)
News (314018)
Policy (31041)
Tag
Academia (2778)
Alliances (49157)
Alzheimer's disease (1279)
Approvals (15147)
Artificial intelligence (133)
Bankruptcy (336)
Best Places to Work (11068)
Biotechnology (187)
Breast cancer (113)
Cancer (989)
Cardiovascular disease (89)
Career advice (2358)
Cell therapy (230)
Clinical research (63149)
Collaboration (352)
Compensation (117)
COVID-19 (2631)
C-suite (91)
Data (910)
Diabetes (148)
Diagnostics (6028)
Drug pricing (93)
Earnings (60504)
Employer resources (149)
Events (89977)
Executive appointments (261)
FDA (15699)
Funding (307)
Gene therapy (168)
GLP-1 (623)
Government (4446)
Healthcare (17940)
Infectious disease (2716)
Inflammatory bowel disease (106)
Interviews (557)
IPO (14334)
Job creations (3426)
Job search strategy (1963)
Layoffs (425)
Legal (6978)
Lung cancer (170)
Manufacturing (169)
Medical device (11911)
Medtech (11915)
Mergers & acquisitions (18077)
Metabolic disorders (407)
Neuroscience (1546)
NextGen Class of 2024 (6454)
Non-profit (4479)
Northern California (1191)
Obesity (235)
Opinion (226)
Patents (102)
People (55218)
Phase I (19585)
Phase II (27773)
Phase III (20904)
Pipeline (254)
Postmarket research (2576)
Preclinical (8169)
Radiopharmaceuticals (238)
Rare diseases (199)
Real estate (5528)
Regulatory (20894)
Research institute (2411)
Resumes & cover letters (433)
Southern California (1085)
Startups (3521)
United States (11272)
Vaccines (578)
Weight loss (188)
Date
Today (196)
Last 7 days (850)
Last 30 days (3034)
Last 365 days (34530)
2024 (29926)
2023 (38364)
2022 (49304)
2021 (53302)
2020 (51872)
2019 (45323)
2018 (34483)
2017 (31682)
2016 (30469)
2015 (35206)
2014 (28766)
2013 (24773)
2012 (24679)
2011 (25457)
2010 (23243)
Location
Africa (897)
Arizona (133)
Asia (38835)
Australia (7551)
California (2690)
Canada (1121)
China (218)
Colorado (117)
Connecticut (119)
Europe (88173)
Florida (394)
Georgia (93)
Illinois (313)
Indiana (185)
Kansas (97)
Maryland (521)
Massachusetts (2083)
Michigan (136)
Minnesota (235)
New Jersey (809)
New York (813)
North Carolina (667)
Northern California (1191)
Ohio (124)
Pennsylvania (679)
South America (1208)
Southern California (1085)
Texas (374)
Washington State (318)
632,132 Results for "kuros biosciences formally known as cytos biotech merged with kuros biosurgery".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Annual General Meeting of Kuros Biosciences Approves All Resolutions
Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today.
April 17, 2024
·
2 min read
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences, a leader in next generation bone healing technologies, announced the publication of a peer-reviewed manuscript that details the clinical data of its MAXA Level 1 prospective, multi-center, randomized, intra-patient controlled clinical study in Spine 1.
June 25, 2024
·
6 min read
Press Releases
Kuros Biosciences Reports First Half of 2024 Results
August 8, 2024
·
8 min read
Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales
Kuros Biosciences, a leader in advanced bone healing technologies, announced its financial performance for the first quarter of 2024.
April 24, 2024
·
6 min read
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences, a leader in next generation bone graft technologies, announced it will present at the CG 2024 Musculoskeletal Conference, to be held in San Francisco on February 12, 2024.
February 1, 2024
·
3 min read
Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that MagnetOs Flex Matrix has been cleared for use in the interbody space by the U.S. Food and Drug Administration (FDA).
November 28, 2023
·
5 min read
Business
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Kuros Biosciences, a leader in next-generation bone graft technologies, announced that it will report its full-year financial results and provide a corporate update on its business on March 13, 2024.
March 8, 2024
·
1 min read
Press Releases
Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024
October 10, 2024
·
6 min read
Press Releases
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
October 23, 2024
·
4 min read
Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023
Kuros Biosciences, a leader in next-generation bone graft technologies, announced financial results for full year 2023 along with continued significant growth.
March 13, 2024
·
10 min read
1 of 63,214
Next
